As part of a special winter series featuring highlights from recent Julius Baer podcasts, today's show features a recent conversation on biotechnology between healthcare analyst Fabian Wenner and equity specialist Yaw Shin Wong on the Julius Baer Beyond Markets podcast. Together they talk about the fundamentals of this segment of healthcare, mRNA technology and the number of acquisitions taking place.

Our regular programme featuring daily market news returns on Thursday 4th January.

00:00 Introduction by Helen Freer (Investment Writing)
00:41  Biotechnology by Fabian Wenner (Healthcare Analyst) and Yaw Shin Wong (Equity Specialist Asia)
05:57 Closing remarks by Helen Freer (Investment Writing)

Would you like to support this show? Please leave us a review and star rating on Apple Podcasts, Spotify or your favourite podcast player.